相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term Persistence with Mirabegron versus Solifenacin in Women with Overactive Bladder: Prospective, Randomized Trial
Manami Kinjo et al.
LUTS-LOWER URINARY TRACT SYMPTOMS (2018)
A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)
David Staskin et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2018)
Patient-reported outcomes from SYNERGY, a randomized, double-blind, multicenter study evaluating combinations of mirabegron and solifenacin compared with monotherapy and placebo in OAB patients
Dudley Robinson et al.
NEUROUROLOGY AND URODYNAMICS (2018)
Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis
Con Kelleher et al.
EUROPEAN UROLOGY (2018)
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)
Christian Gratzke et al.
EUROPEAN UROLOGY (2018)
Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)
Sender Herschorn et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2018)
Cardiovascular Safety of the 3-Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial
William B. White et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Real-world persistence and adherence to oral antimuscarinics and mirabegron in patients with overactive bladder (OAB): a systematic literature review
Gillian Yeowell et al.
BMJ OPEN (2018)
Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE)
Marcus J. Drake et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2017)
Persistence and adherence with mirabegron vs antimuscarinics in overactive bladder: Retrospective analysis of a UK General Practice prescription database
Adrian S. Wagg et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2017)
Indirect treatment comparison (ITC) of medical therapies for an overactive bladder
Aneta Obloza et al.
NEUROUROLOGY AND URODYNAMICS (2017)
Comparative assessment of the efficacy of onabotulinumtoxinA and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis
Marcus J. Drake et al.
BJU INTERNATIONAL (2017)
Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study)
Sender Herschorn et al.
BJU INTERNATIONAL (2017)
On the Site and Mechanism of Action of β3-Adrenoceptor Agonists in the Bladder
Karl Erik Andersson
INTERNATIONAL NEUROUROLOGY JOURNAL (2017)
Patient-reported outcomes with the 3-adrenoceptor agonist mirabegron in a phase III trial in patients with overactive bladder
Vik Khullar et al.
NEUROUROLOGY AND URODYNAMICS (2016)
Patient and physician preferences for oral pharmacotherapy for overactive bladder: two discrete choice experiments
M. Heisen et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)
Marcus J. Drake et al.
EUROPEAN UROLOGY (2016)
Comparison of Therapeutic Efficacy and Urodynamic Findings of Solifenacin Succinate versus Mirabegron in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Study
Carlo Vecchioli Scaldazza et al.
UROLOGIA INTERNATIONALIS (2016)
A randomized, controlled trial of effectiveness and safety of management of OAB symptoms in elderly men and women with standard-dosed combination of solifenacin and mirabegron
Kirill Kosilov et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2015)
Combination Treatment with Mirabegron and Solifenacin in Patients with Overactive Bladder: Efficacy and Safety Results from a Randomised, Double-blind, Dose-ranging, Phase 2 Study (Symphony)
Paul Abrams et al.
EUROPEAN UROLOGY (2015)
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment
E. Ann Gormley et al.
JOURNAL OF UROLOGY (2015)
Comparison of solifenacin and fesoterodine in treatment of overactive bladder
Onder Ercan et al.
SAUDI MEDICAL JOURNAL (2015)
Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years
Mina Jafarabadi et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2015)
Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a 3-adrenoceptor agonist, in patients with overactive bladder in Asia
Hann-Chorng Kuo et al.
NEUROUROLOGY AND URODYNAMICS (2015)
The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial
Jose E. Batista et al.
THERAPEUTIC ADVANCES IN UROLOGY (2015)
Phase III, randomised, double-blind, placebo-controlled study of the 3-adrenoceptor agonist mirabegron, 50mg once daily, in Japanese patients with overactive bladder
Osamu Yamaguchi et al.
BJU INTERNATIONAL (2014)
Comparative Efficacy and Safety of Medical Treatments for the Management of Overactive Bladder: A Systematic Literature Review and Mixed Treatment Comparison
Khaled Maman et al.
EUROPEAN UROLOGY (2014)
Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: Results of a real-life clinical study
Hironobu Akino et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
What is the success of drug treatment in urge urinary incontinence? What should be measured?
Hulya Dede et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2013)
Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European-Australian Phase 3 Trial
Vik Khullar et al.
EUROPEAN UROLOGY (2013)
A phase II dose-ranging study of mirabegron in patients with overactive bladder
Christopher R. Chapple et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2013)
Methods for the Drug Effectiveness Review Project
Marian S. McDonagh et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
Racial Differences in the Prevalence of Overactive Bladder in the United States From the Epidemiology of LUTS (EpiLUTS) Study
Karin S. Coyne et al.
UROLOGY (2012)
Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults
Bhavan Prasad Rai et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Which anticholinergic drug for overactive bladder symptoms in adults
Priya Madhuvrata et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Tolerability of solifenacin and oxybutynin immediate release in older (>65 years) and younger (≤65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study
S. Herschorn et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Fesoterodine: Individualised Treatment of Urgency Urinary Incontinence Across Patient Groups
Jean-Jacques Wyndaele
EUROPEAN UROLOGY SUPPLEMENTS (2011)
Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome
Sheng-Mou Hsiao et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2011)
Responsiveness and Minimal Clinically Important Change in Overactive Bladder Symptom Score
Momokazu Gotoh et al.
UROLOGY (2011)
The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS
Karin S. Coyne et al.
BJU INTERNATIONAL (2009)
Gabapentin Versus Tricyclic Antidepressants for Diabetic Neuropathy and Post-Herpetic Neuralgia: Discrepancies Between Direct and Indirect Meta-Analyses of Randomized Controlled Trials
Roger Chou et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study
Karin S. Coyne et al.
BJU INTERNATIONAL (2008)
Determining the importance of change in the overactive bladder questionnaire
Karin S. Coyne et al.
JOURNAL OF UROLOGY (2006)
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder
Paul Abrams et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
The validation of the patient perception of bladder condition (PPBC): A single-item global measure for patients with overactive bladder
Karin S. Coyne et al.
EUROPEAN UROLOGY (2006)
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries
DE Irwin et al.
BJU INTERNATIONAL (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Recent developments in the management of detrusor overactivity
V Kumar et al.
CURRENT OPINION IN UROLOGY (2003)
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: Results of the OPERA trial
AC Diokno et al.
MAYO CLINIC PROCEEDINGS (2003)
The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder
S Garnett et al.
JOURNAL OF UROLOGY (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Prevalence and burden of overactive bladder in the United States
WF Stewart et al.
WORLD JOURNAL OF UROLOGY (2002)
The standardisation of terminology of lower urinary tract function: Report from the of the International Standardisation Sub-Committee Continence Society
P Abrams et al.
NEUROUROLOGY AND URODYNAMICS (2002)
BPH with coexisting overactive bladder dysfunction - An everyday urological dilemma
T Knutson et al.
NEUROUROLOGY AND URODYNAMICS (2001)
Empirical assessment of effect of publication bias on meta-analyses
AJ Sutton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
